Aptadel Therapeutics
PrivateLast Round
VC Round
Mar 24, 2026
Total Funding Raised
$2.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Aptadel Therapeutics is a drug discovery company developing an RNA-based platform of targeted therapy to treat cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aptadel Therapeutics Comparables
Compare Aptadel Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RNA Nanotherapeutics | 72% | |
| TME Pharma N.V. | 67% | |
| Aptamer Sciences Inc | 66% |
Aptadel Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 24, 2026 | ||||
| Grant | Feb 11, 2025 | ||||
| Seed | Jan 21, 2021 |
Aptadel Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Newsight Tech Angels | VC Round |
| Little Warrior Foundation | VC Round, Grant |
| Fundación Alba Pérez | Seed |
| Chasing Science | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 43% MoM.
- Apr 22, 2026
Monthly visitors increased 180% MoM, reaching 829.
Aptadel Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aptadel Therapeutics's valuation, stock price, and market status.
Is Aptadel Therapeutics a public or private company?
Aptadel Therapeutics is a private company.
What is the current stock price of Aptadel Therapeutics?
Aptadel Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Aptadel Therapeutics worth (valuation)?
Valuation information for Aptadel Therapeutics is not publicly available.
Can I buy Aptadel Therapeutics stock?
Aptadel Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aptadel Therapeutics's last funding round?
Aptadel Therapeutics's most recent funding round was VC Round on March 24, 2026.
Who are the main investors in Aptadel Therapeutics?
Key investors in Aptadel Therapeutics include Newsight Tech Angels.
Will Aptadel Therapeutics IPO soon?
No public IPO plans have been announced for Aptadel Therapeutics.
How can I track Aptadel Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aptadel Therapeutics's secondary market activity and sign up for updates.